MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma

Qian,Zhenyuan; Gong,Lijie; Mou,Yiping; Han,Yong; Zheng,Shusen

doi:10.3892/or.2019.7310

MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma

Authors:
- Zhenyuan Qian
- Lijie Gong
- Yiping Mou
- Yong Han
- Shusen Zheng
View Affiliations

Affiliations: Zhejiang University School of Medicine, Hangzhou, Zhejiang 310058, P.R. China, Department of Breast Surgery, Zhejiang Cancer Hospital, Hangzhou, Zhejiang 310022, P.R. China, Department of Gastrointestinal and Pancreatic Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China, Clinical Research Institute of Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang 310014, P.R. China
Published online on: September 12, 2019 https://doi.org/10.3892/or.2019.7310
Pages: 1825-1832
Copyright: © Qian et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the role of miR‑203a‑3p in colorectal cancer (CRC) and identify the target gene of microRNA (miR)‑203a‑3p. A total of 59 sets of cancer tissues and corresponding adjacent non‑tumor tissues were collected from CRC patients (aged 31‑78 years) between October 2016 and May 2017. Total RNA extraction and reverse transcription‑quantitative polymerase chain reaction analysis, transfection assay, and Transwell and apoptosis assays, western blot analysis, a luciferase reporter assay and immunohistochemistry were performed. miR‑203a‑3p was found to be significantly downregulated in CRC tissues compared with adjacent normal tissues. The overexpression of miR‑203a‑3p was shown to inhibit the invasion and migration of human CRC SW480 and HT29 cells, and increase their apoptosis rates. Furthermore, miR‑203a‑3p downregulated the expression of thrombospondin 2 (THBS2) in SW480 and HT29 cells. It was also experimentally demonstrated that miR‑203a‑3p binds to the 3'‑untranslated region of THBS2, downregulating THBS2 expression and thereby inhibiting CRC progression and metastasis. The expression of miR‑203a‑3p, which serves a tumor‑suppressive role, in CRC tissues was significantly downregulated. As miR‑203a‑3p was determined to target THBS2 to inhibit CRC progression and metastasis; thus, miR‑203a‑3p may be considered as a potential novel approach to treating CRC.

View Figures

View References

1	Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
2	Fidler MM, Gupta S, Soerjomataram I, Ferlay J, Steliarova-Foucher E and Bray F: Cancer incidence and mortality among young adults aged 20–39 years worldwide in 2012: A population-based study. Lancet Oncol. 18:1579–1589. 2017. View Article : Google Scholar : PubMed/NCBI
3	Ameres SL and Zamore PD: Diversifying microRNA sequence and function. Nat Rev Mol Cell Biol. 14:475–488. 2013. View Article : Google Scholar : PubMed/NCBI
4	Jafri MA, Al-Qahtani MH and Shay JW: Role of miRNAs in human cancer metastasis: Implications for therapeutic intervention. Semin Cancer Biol. 44:117–131. 2017. View Article : Google Scholar : PubMed/NCBI
5	Friedman RC, Farh KH, Burge CB and Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
6	Liu X, Chen X, Zeng K, Xu M, He B, Pan Y, Sun H, Pan B, Xu X, Xu T, et al: DNA-methylation-mediated silencing of miR-486-5p promotes colorectal cancer proliferation and migration through activation of PLAGL2/IGF2/β-catenin signal pathways. Cell Death Dis. 2018. View Article : Google Scholar
7	Feng L, Jing L, Han J, Wang G and Liu Y, Zhang X, Wang Y, Wang F, Ma H and Liu Y: MicroRNA 486-3p directly targets BIK and regulates apoptosis and invasion in colorectal cancer cells. Onco Targets Ther. 11:8791–8801. 2018. View Article : Google Scholar : PubMed/NCBI
8	Han C, Song Y and Lian C: MiR-769 inhibits colorectal cancer cell proliferation and invasion by targeting HEY1. Med Sci Monit. 24:9232–9239. 2018. View Article : Google Scholar : PubMed/NCBI
9	Mizoguchi A, Takayama A, Arai T, Kawauchi J and Sudo H: MicroRNA-8073: Tumor suppressor and potential therapeutic treatment. PLoS One. 13:e02097502018. View Article : Google Scholar : PubMed/NCBI
10	Yang X, Lou Y, Wang M, Liu C, Liu Y and Huang W: miR675 promotes colorectal cancer cell growth dependent on tumor suppressor DMTF1. Mol Med Rep. 19:1481–1490. 2019.PubMed/NCBI
11	Mazeh H, Mizrahi I, Ilyayev N, Halle D, Brucher B, Bilchik A, Protic M, Daumer M, Stojadinovic A, Itzhak A and Nissan A: The diagnostic and prognostic role of microRNA in colorectal cancer-a comprehensive review. J Cancer. 4:281–295. 2013. View Article : Google Scholar : PubMed/NCBI
12	DeCastro AJ, Dunphy KA, Hutchinson J, Balboni AL, Cherukuri P, Jerry DJ and DiRenzo J: MiR203 mediates subversion of stem cell properties during mammary epithelial differentiation via repression of ΔNP63alpha and promotes mesenchymal-to-epithelial transition. Cell Death Dis. 4:e5142013. View Article : Google Scholar : PubMed/NCBI
13	Hu D, Hu Y, Xu W, Yu H, Yang N, Ni S and Fu R: miR203 inhibits the expression of collagen-related genes and the proliferation of hepatic stellate cells through a SMAD3-dependent mechanism. Mol Med Rep. 16:1248–1254. 2017. View Article : Google Scholar : PubMed/NCBI
14	Liang M, Shi B, Liu J, He L, Yi G, Zhou L, Yu G and Zhou X: Downregulation of miR203 induces overexpression of PIK3CA and predicts poor prognosis of gastric cancer patients. Drug Des Devel Ther. 9:3607–3616. 2015.PubMed/NCBI
15	Xu D, Wang Q, An Y and Xu L: MiR203 regulates the proliferation, apoptosis and cell cycle progression of pancreatic cancer cells by targeting Survivin. Mol Med Rep. 8:379–384. 2013. View Article : Google Scholar : PubMed/NCBI
16	Deng B, Wang B, Fang J, Zhu X, Cao Z, Lin Q, Zhou L and Sun X: MiRNA-203 suppresses cell proliferation, migration and invasion in colorectal cancer via targeting of EIF5A2. Sci Rep. 6:283012016. View Article : Google Scholar : PubMed/NCBI
17	Xiao Z, Qu Z, Chen Z, Fang Z, Zhou K, Huang Z, Guo X and Zhang Y: LncRNA HOTAIR is a prognostic biomarker for the proliferation and chemoresistance of colorectal cancer via MiR-203a-3p-mediated Wnt/ss-catenin signaling pathway. Cell Physiol Biochem. 46:1275–1285. 2018. View Article : Google Scholar : PubMed/NCBI
18	Liu S and Feng P: MiR-203 Determines poor outcome and suppresses tumor growth by targeting TBK1 in osteosarcoma. Cell Physiol Biochem. 37:1956–1966. 2015. View Article : Google Scholar : PubMed/NCBI
19	Burnside MN, Pyatt RE, Hughes A, Baker PB and Pierson CR: Complex brain malformations associated with chromosome 6q27 gain that includes THBS2, which encodes thrombospondin 2, an astrocyte-derived protein of the extracellular matrix. Pediatr Dev Pathol. 18:59–65. 2015. View Article : Google Scholar : PubMed/NCBI
20	Zhuo C, Li X, Zhuang H, Tian S, Cui H, Jiang R, Liu C, Tao R and Lin X: Elevated THBS2, COL1A2, and SPP1 expression levels as predictors of gastric cancer prognosis. Cell Physiol Biochem. 40:1316–1324. 2016. View Article : Google Scholar : PubMed/NCBI
21	Sun R, Wu J, Chen Y, Lu M, Zhang S, Lu D and Li Y: Down regulation of Thrombospondin2 predicts poor prognosis in patients with gastric cancer. Mol Cancer. 13:2252014. View Article : Google Scholar : PubMed/NCBI
22	Fei W, Chen L, Chen J, Shi Q, Zhang L, Liu S, Li L, Zheng L and Hu X: RBP4 and THBS2 are serum biomarkers for diagnosis of colorectal cancer. Oncotarget. 8:92254–92264. 2017. View Article : Google Scholar : PubMed/NCBI
23	Wang X, Zhang L, Li W, Sun H, Zhang H and Lai M: THBS2 is a potential prognostic biomarker in colorectal cancer. Sci Rep. 6:333662016. View Article : Google Scholar : PubMed/NCBI
24	Adolph KW, Liska DJ and Bornstein P: Analysis of the promoter and transcription start sites of the human thrombospondin 2 gene (THBS2). Gene. 193:5–11. 1997. View Article : Google Scholar : PubMed/NCBI
25	Bornstein P, O'Rourke K, Wikstrom K, Wolf FW, Katz R, Li P and Dixit VM: A second, expressed thrombospondin gene (Thbs2) exists in the mouse genome. J Biol Chem. 266:12821–12824. 1991.PubMed/NCBI
26	Ao R, Guan L, Wang Y and Wang JN: Silencing of COL1A2, COL6A3, and THBS2 inhibits gastric cancer cell proliferation, migration, and invasion while promoting apoptosis through the PI3k-Akt signaling pathway. J Cell Biochem. 119:4420–4434. 2018. View Article : Google Scholar : PubMed/NCBI
27	Chang IW, Li CF, Lin VC, He HL, Liang PI, Wu WJ, Li CC and Huang CN: Prognostic impact of thrombospodin-2 (THBS2) overexpression on patients with urothelial carcinomas of upper urinary tracts and bladders. J Cancer. 7:1541–1549. 2016. View Article : Google Scholar : PubMed/NCBI
28	Lin X, Hu D, Chen G, Shi Y, Zhang H, Wang X, Guo X, Lu L, Black D, Zheng XW and Luo X: Associations of THBS2 and THBS4 polymorphisms to gastric cancer in a Southeast Chinese population. Cancer Genet. 209:215–222. 2016. View Article : Google Scholar : PubMed/NCBI
29	Tsai EA, Gilbert MA, Grochowski CM, Underkoffler LA, Meng H, Zhang X, Wang MM, Shitaye H, Hankenson KD, Piccoli D, et al: THBS2 is a candidate modifier of liver disease severity in alagille syndrome. Cell Mol Gastroenterol Hepatol. 2:663–675. 2016. View Article : Google Scholar : PubMed/NCBI
30	Wei WF, Zhou CF, Wu XG, He LN, Wu LF, Chen XJ, Yan RM, Zhong M, Yu YH, Liang L and Wang W: MicroRNA-221-3p, a TWIST2 target, promotes cervical cancer metastasis by directly targeting THBS2. Cell Death Dis. 8:32202017. View Article : Google Scholar : PubMed/NCBI
31	Liu S, Dong H, Dai H, Liu D and Wang Z: MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9. Oncol Lett. 15:10077–10083. 2018.PubMed/NCBI:
32	Zhang Y, Su Y, Zhao Y, Lv G and Luo Y: MicroRNA720 inhibits pancreatic cancer cell proliferation and invasion by directly targeting cyclin D1. Mol Med Rep. 16:9256–9262. 2017. View Article : Google Scholar : PubMed/NCBI